Sumatriptan Injection
- All
- News
-
Dr Reddy's hits record high on migraine drug launch in US
Macquarie upgraded its price target for Dr. Reddy's shares to Rs 3,325 from Rs 3,200, saying its US business was "significantly under appreciated by the street.
-
Dr Reddy's launches auto-injector system in US
The injection is an auto-injector system for subcutaneous use. It is a therapeutic equivalent generic version of Imitrex Statdose Pen (sumatriptan succinate) and was launched in the US market today following approval by the United States Food & Drug Administration (USFDA), a company statement said.
-
Strides Arcolab announces US FDA approval of Sumatriptan Succinate Injection
Strides Arcolab has announced that the U.S. Food and Drug Administration had granted approval of Sumatriptan Succinate Injection 6 mg (base)/0.5 mL, a selective agonist for a vascular 5-hydroxytryptaminei receptor subtype. It is used for the acute treatment of migraine attacks with or without aura and the acute treatment of cluster headache episode...
-
Strides Arco - Strides Arcolab announces US FDA approval of Sumatriptan Succinate Injection - Eleventh Sterile injectables approval in 2010
Strides Arcolab Ltd has informed BSE regarding a Press Release dated July 30, 2010 titled "Strides Arcolab announces US FDA approval of Sumatriptan Succinate Injection - Eleventh Sterile injectables approval in 2010"
-
Dr Reddy's hits record high on migraine drug launch in US
Macquarie upgraded its price target for Dr. Reddy's shares to Rs 3,325 from Rs 3,200, saying its US business was "significantly under appreciated by the street.
-
Dr Reddy's launches auto-injector system in US
The injection is an auto-injector system for subcutaneous use. It is a therapeutic equivalent generic version of Imitrex Statdose Pen (sumatriptan succinate) and was launched in the US market today following approval by the United States Food & Drug Administration (USFDA), a company statement said.
-
Strides Arcolab announces US FDA approval of Sumatriptan Succinate Injection
Strides Arcolab has announced that the U.S. Food and Drug Administration had granted approval of Sumatriptan Succinate Injection 6 mg (base)/0.5 mL, a selective agonist for a vascular 5-hydroxytryptaminei receptor subtype. It is used for the acute treatment of migraine attacks with or without aura and the acute treatment of cluster headache episode...
-
Strides Arco - Strides Arcolab announces US FDA approval of Sumatriptan Succinate Injection - Eleventh Sterile injectables approval in 2010
Strides Arcolab Ltd has informed BSE regarding a Press Release dated July 30, 2010 titled "Strides Arcolab announces US FDA approval of Sumatriptan Succinate Injection - Eleventh Sterile injectables approval in 2010"
